BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) entered into a definitive agreement with Luitpold Pharmaceuticals Inc., under which it ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE